JPRN-UMIN000028332
Completed
未知
Evaluation of tumor hypoxia for stereotactic radiotherapy using F-18 fluoromisonidazole - Evaluation of tumor hypoxia for stereotactic radiotherapy using F-18 fluoromisonidazole
Conditionsung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- ung cancer
- Sponsor
- Kindai University
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)During the pregnancy or a pregnant female patient we are possible or are nursing. 2\)The patient whom we merge psychosis or neurological manifestation, and it is judged to have difficulty with participation to an examination. 3\)Severe complications whom enable to perform PET/CT 4\)Other reasons with inadequate to enroll this trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Assessment of tumor hypoxia during radiotherapy course in locally advanced Head and Neck cancer with 18F-fluoroazomycin arabinoside (18F-FAZA)-PET-CThoofd hals kankerHypoxia in locally advanced Head and Neck cancer10027656NL-OMON36574niversitair Medisch Centrum Groningen20
Withdrawn
Not Applicable
A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZAHypoxic TumoursNCT00756691AHS Cancer Control Alberta
Completed
Not Applicable
Assessment of tumor hypoxia in laryngeal cancer with 18F-fluoroazomycin arabinoside (18F-FAZA)-PET/CT scanning, oxygen-enhanced MRI (OE-MRI) and immunohistochemistryNL-OMON33970niversitair Medisch Centrum Groningen12
Completed
Phase 2
Hypofractionated stereotactic radiotherapy for large brain metastasesBrain metastasesJPRN-UMIN000010112Department of Radiology, Nagoya City University Graduate School of Medical Sciences90
Not yet recruiting
Phase 2
Validation of hypoxia imaging of cancer in the head and neck area with FAZA-PETNL-OMON32369Antoni van Leeuwenhoek Ziekenhuis20